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Introduction
Urban particulate matter (PM) in ambient air 
is a complex mixture of various sizes of parti-
cles, and is generally categorized into coarse 
[mass median aerodynamic diameter (MMAD) 
2.5–10 μm; PM10–2.5],  f ine (MMAD 
≤ 2.5 μm; PM2.5), and ultrafine (MMAD 
≤ 0.1 μm) particles. In urban centers, sources of 
PM2.5 and ultrafine particles typically originate 
from mobile and industrial fossil fuel combus-
tion, whereas PM10–2.5 often originates from 
dust and soil as well as mechanical abrasive 
processes from industrial and transporta-
tion sectors (HEI Review Panel on Ultrafine 
Particles 2013). Coarse PM often contains 
bacterial constituents (Schins et al. 2004). The 
adverse health effects of PM2.5 in ambient air 
on population mortality and hospital admis-
sions have been extensively studied and 
reviewed (World Health Organization 2013). 
Many changes in lung and cardiovascular 
physiology (Liu et al. 2009a; Pope et al. 2004) 
and biological mediators in blood (Chuang 
et al. 2007; Delfino et al. 2009; Rückerl et al. 
2007) have also been observed on high PM2.5 
concentration days in epidemiological studies.
Recent studies have reported the mortality 
and morbidity effects of PM10–2.5 (Stafoggia 
et al. 2013; Zanobetti and Schwartz 2009) 
and ultrafine particles (HEI Review Panel 
on Ultrafine Particles 2013). Relative to 
fine PM, few studies have documented the 
associations between exposure to PM10–2.5 or 
ultrafine particles and airway inflammation 
and systemic outcomes in epidemiological 
studies (Lipsett et al. 2006; Pekkanen et al. 
2002) or controlled human exposure studies 
(Behbod et al. 2013; Brook et al. 2013; 
Graff et al. 2009; Samet et al. 2009). Few 
studies have compared how these ambient 
particle size fractions affect systemic inflam-
mation and oxidative stress in the human 
body. A toxicological study has shown that 
on a comparative mass basis, coarse, fine, and 
ultrafine PM affected murine lungs and hearts 
in a different manner, with coarse PM more 
potently influencing airway inflammation 
and ultrafine particles more potently influ-
encing cardiac function (Cho et al. 2009). 
Samet et al. (2007) summarized findings from 
their controlled human exposure studies: 
Exposures to concentrated ambient PM2.5 
and PM10–2.5 were associated with increased 
airway inflammation and a trend of increased 
blood coagulation markers such as fibrinogen 
and plasminogen, but exposure to ultrafine 
particles had no such effects. 
Endotoxin is a major constituent of the 
outer membrane of the cell wall of gram-
negative bacteria, and in blood triggers the 
signaling cascade for macrophage/endothelial 
cells to secrete proinflammatory cytokines 
(Copeland et al. 2005). β-1,3-d-glucan 
(glucan) comes from the cell wall of fungi 
and plants, and is known to be a modulator 
of immune system function (Fogelmark et al. 
1994). Although endotoxin and glucan in 
indoor dust have been associated with respira-
tory illness in children (Dales et al. 2006; 
Douwes et al. 2000), little is known about 
the adverse health effects of these biological 
constituents in outdoor PM.
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Background: Ambient coarse, fine, and ultrafine particles have been associated with mortality and 
morbidity. Few studies have compared how various particle size fractions affect systemic biomarkers.
oBjectives: We examined changes of blood and urinary biomarkers following exposures to three 
particle sizes.
Methods: Fifty healthy nonsmoking volunteers, mean age of 28 years, were exposed to coarse 
(2.5–10 μm; mean, 213 μg/m3) and fine (0.15–2.5 μm; mean, 238 μg/m3) concentrated ambient 
particles (CAPs), and filtered ambient and/or medical air. Twenty-five participants were exposed 
to ultrafine CAP ( < 0.3 μm; mean, 136 μg/m3) and filtered medical air. Exposures lasted 130 min, 
separated by ≥ 2 weeks. Blood/urine samples were collected preexposure and 1 hr and 21 hr post-
exposure to determine blood interleukin-6 and C-reactive protein (inflammation), endothelin-1 
and vascular endothelial growth factor (VEGF; vascular mediators), and malondialdehyde (lipid 
peroxidation); as well as urinary VEGF, 8-hydroxy-deoxy-guanosine (DNA oxidation), and 
 malondialdehyde. Mixed-model regressions assessed pre- and postexposure differences.
results: One hour postexposure, for every 100-μg/m3 increase, coarse CAP was associated with 
increased blood VEGF (2.41 pg/mL; 95% CI: 0.41, 4.40) in models adjusted for O3, fine CAP 
with increased urinary malondialdehyde in single- (0.31 nmol/mg creatinine; 95% CI: 0.02, 0.60) 
and two-pollutant models, and ultrafine CAP with increased urinary 8-hydroxydeoxyguanosine 
in single- (0.69 ng/mg creatinine; 95% CI: 0.09, 1.29) and two-pollutant models, lasting < 21 hr. 
Endotoxin was significantly associated with biomarker changes similar to those found with CAPs.
conclusions: Ambient particles with various sizes/constituents may influence systemic biomarkers 
differently. Endotoxin in ambient particles may contribute to vascular mediator changes and 
oxidative stress.
citation: Liu L, Urch B, Poon R, Szyszkowicz M, Speck M, Gold DR, Wheeler AJ, Scott JA, 
Brook JR, Thorne PS, Silverman FS. 2015. Effects of ambient coarse, fine, and ultrafine particles 
and their biological constituents on systemic biomarkers: a controlled human exposure study. 
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In this study, we hypothesized that a) a 
short-term exposure to concentrated ambient 
coarse, fine, or ultrafine PM would be associ-
ated with increased systemic inflammation, 
oxidative stress, and changes in mediators 
of vascular function in healthy individuals, 
detectable through biomarkers; and b) primary 
biological material in these particles might 
play a role in concentrated ambient particle 
(CAP)–related systemic effects.
Materials and Methods
Study participants. The study design was a 
single-blind randomized crossover trial. We 
recruited participants through advertising on 
a local university campus. Participants were 
nonsmokers, 18–60 years of age, without 
history of coronary artery disease, myocar-
dial infarction, peripheral vascular disease, 
angina, heart failure, hypertension, or diabetes 
mellitus. All participants were free of lipid 
abnormalities and respiratory tract infec-
tions. We excluded participants with baseline 
spirometry < 75% of predicted normal values 
(forced vital capacity and forced expiratory 
1-sec volume), having clinically significant 
abnormalities in their resting electrocardio-
gram, or being pregnant or breastfeeding. 
All participants provided informed written 
consent prior to participating in the study. 
The Research Ethics Boards of Health Canada, 
St. Michael’s Hospital, and the University of 
Toronto approved the study protocol.
Exposure facility. Details of the coarse, 
fine, and ultrafine particle concentrator 
facility were described elsewhere (Rastogi et al. 
2012). The controlled exposures to CAPs 
drew air from breathing height adjacent to 
a downtown street in Toronto, Canada. We 
used the Harvard Ambient Fine and Coarse 
Particle Concentrators (Harvard School of 
Public Health) and an enclosed temperature-
controlled exposure chamber for the study 
participants. Ambient aerosols were drawn 
through a size-selective inlet where particles 
>10 μm were removed. The fine PM concen-
trator delivered CAP 0.15–2.5 μm in MMAD 
(fine CAP), and the coarse PM concentrator 
delivered CAP 2.5–10 μm in MMAD (coarse 
CAP). Particle-free filtered ambient air (FA) 
was used as a control by inserting a high-
efficiency particulate absorption (HEPA) filter 
inline downstream of the particle concentrator. 
For the study on coarse and fine CAPs, we 
enrolled 50 participants. Early in the study, 
we observed a pattern of similar postexposure 
changes in outcome measures (for example, 
blood pressure and blood neutrophils) for FA 
and CAP exposures. We hypothesized that 
ambient gaseous pollutants may have contrib-
uted to the FA responses. To explore this possi-
bility, for another exposure to 41 participants, 
we added HEPA-filtered cylinder medical air 
that was particle- and ambient gas–free. The 
study for the coarse and fine CAPs included 
up to five exposures for each participant when 
he or she was available: two exposures to coarse 
CAP, and one exposure to fine CAP, HEPA-
filtered ambient air, and/or filtered medical air.
In the airstream of the ultrafine particle 
concentrator, particles > 0.3 μm were removed 
by inertial impaction to deliver a concentrated 
ultrafine aerosol to the participant. For the 
study on ultrafine CAP, we used the HEPA-
filtered medical air as control. Twenty-five 
participants completed the ultrafine CAP 
study, 20 of whom also participated in the 
coarse and fine CAP study.
The exposure air stream was delivered 
directly to the participant who was seated at 
rest and breathing freely via an “oxygen type” 
face mask covering his/her nose and mouth. 
Each exposure lasted 130 min. PM in the 
airstream was collected on a filter during the 
130-min exposure, and gravimetric deter-
minations of mass concentrations reported. 
Between exposures there was a washout period 
of ≥ 2 weeks.
Gaseous pollutant monitoring .  We 
measured concentrations of gaseous pollut-
ants in the exposure facility in the airstream 
delivered to the participant. Gases measured 
included sulfur dioxide (SO2, fluorescent; 
Monitor Labs model 8850), ozone (O3, ultra-
violet photometric; Dasibi model 1008RS), 
nitrogen dioxide (NO2, chemiluminescent; 
Monitor Labs model 8840), and carbon 
monoxide (CO, infrared; Thermo Electron 
Instruments model 49). We reported the 
mean of the 15-sec averages for the 130-min 
exposure period.
Measurement of endotoxin and glucan. 
Detailed methods for the measurements 
of endotoxin and glucan were previously 
described (Behbod et al. 2013). Endotoxin 
and glucan were collected on polycarbonate 
membrane filters during exposures to CAPs 
and filtered ambient air (but not filtered 
medical air). Natural log transformation was 
performed on endotoxin and glucan concen-
trations [ln(value+1)] to obtain a normal 
distribution of the data.
Measurement of biomarkers in blood and 
urine. We collected urine and venous blood 
samples (20 mL) before and at 1 hr and 21 hr 
after each exposure. Upon participants’ arrival 
for the first exposure, their preexposure blood 
and urine samples were used to determine 
baseline values. We measured their height and 
weight and calculated body mass index (BMI) 
using the standard procedures.
Blood tests. We obtained fasting blood 
samples by venipuncture and stored plasma 
at –70°C. High sensitivity C-reactive protein 
(CRP) was analyzed using ELISA kit from 
Alpco Laboratory Products Company (Salem, 
NH, USA); interleukin-6 (IL-6), endothelin-1 
(ET-1), and vascular endothelial growth factor 
(VEGF) were analyzed using ELISA kits from 
R&D Systems (Minneapolis, MN, USA). 
Malondialdehyde (MDA) was measured 
using high-performance liquid chromato-
graphy (HPLC) with an Agilent 1200 series 
system (Agilent Technologies, Mississauga, 
Ontario, Canada).
Urine tests. We collected and stored urine 
samples at –20°C. Urine samples were clarified 
by centrifugation (5,000 rpm, 5 min in an 
Eppendorf 5804 centrifuge) before analyses. 
VEGF and 8-hydroxydeoxyguanosine 
(8-OHdG) were measured using ELISA kits 
(8-OHdG kit; Cosmo Bio USA, Carlsbad, 
CA, USA). HPLC analysis was used to 
measure urinary MDA. Creatinine concentra-
tions were measured using a CREA kit (Roche 
Diagnostics, Laval, Quebec, Canada) to 
normalize urinary biomarker concentrations.
Statistical analysis. We tested statistically 
significant differences in concentrations of 
endotoxin, glucan, and gases among exposure 
scenarios using Kruskal–Wallis one-way 
analysis of variance (ANOVA), followed by 
Dunn’s test of pairwise multiple comparisons. 
We tested correlations between total mass 
concentrations of CAPs, gaseous pollutants, 
and endotoxin and glucan concentrations using 
the nonparametric Spearman rank order corre-
lation. We subtracted preexposure biomarker 
values from 1-hr and 21-hr postexposure values 
to adjust for the participant’s day-to-day varia-
tions in factors such as daily diet and exposure 
to ambient pollutants and environmental 
tobacco smoke that may also contribute to 
variations in systemic biomarker levels.
We used mixed-effects linear regression 
models (restricted maximum likelihood 
estimation) to analyze a) the associations 
between biomarkers and particle concentra-
tions measured in the airstreams; and b) the 
associations between biomarkers and concen-
trations of endotoxin or glucan collected 
during exposures. Mixed models accounted 
for the repeated measures, assuming random 
participant intercepts and random slopes. We 
used an autoregressive model of order-one to 
adjust for serial autocorrelation. The statis-
tical software used was S-PLUS® version 6.2 
(TIBCO Software Inc., Palo Alto, CA, USA). 
Age, sex (binary variable, male = 1), BMI, and 
season [binary variable, warm season (May–
October) = 1] were included in all models. 
Because temperature was controlled and 
relative humidity was constant in the testing 
facility, we did not adjust for them in the 
models. Endotoxin and glucan were consid-
ered part of the particle constituents, and their 
concentrations were correlated with coarse and 
fine CAP concentrations (see “Results”). To 
avoid multicollinearity, we did not include 
them as covariates in any models with CAPs.
Because gaseous pollutant concentra-
tions varied among exposure scenarios and 
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might affect systemic biomarker levels, for 
a sensitivity analysis we included gaseous 
pollutants in the airstream as a covariate in 
two-pollutant models.
Regression results were expressed as mean 
change in biomarker concentrations [95% 
confidence interval (CI)]. A two-tailed value of 
p ≤ 0.05 was considered statistically significant.
Results
For the study on coarse and fine CAPs, we 
recruited in total 58 subjects. Eight subjects 
withdrew from the study, one due to high 
blood pressure, another due to high blood 
cholesterol level, and six due to time conflicts. 
For the ultrafine CAP study, five additional 
subjects were enrolled to make the total 
sample size of 25 subjects. In total, 55 female 
and male participants were enrolled. For the 
characteristics of the cohort, see Supplemental 
Material,Table S1.
Table 1 presents air pollutant concen-
trations in the exposure airstreams of CAP, 
filtered ambient, and filtered medical air deliv-
ered to the participants. The temperature and 
relative humidity were stable (mean ± SD = 
24.0°C ± 1.2°C and 25.0% ± 12.4%, respec-
tively). Gaseous pollutant concentrations in 
filtered ambient air were not significantly 
different from those in coarse and fine CAPs. 
O3, NO2, and CO concentrations in filtered 
medical air were significantly lower than in the 
CAPs exposure air.
Endotoxin and glucan concentrations in 
coarse and fine CAPs were similar, but signifi-
cantly higher than in filtered ambient air. The 
endotoxin and glucan levels in filtered medical 
air were nondetectable. Endotoxin and glucan 
concentrations were measured during six ultra-
fine CAP exposures. Ultrafine CAP appears 
to contain the lowest concentrations of endo-
toxin and glucan among the three particle size 
fractions. Mass concentrations of coarse and 
fine CAPs were relatively strongly correlated 
with endotoxin and glucan levels (r = 0.75 and 
0.76 for endotoxin and glucan in coarse CAP, 
respectively, p < 0.001; r = 0.59 and 0.67 for 
endotoxin and glucan in fine CAP, respec-
tively, p < 0.001). Correlations between coarse 
and fine CAP mass concentrations and gas 
concentrations measured in the airstream were 
weak (r-values ranging from –0.25 for correla-
tions between coarse CAP and CO to 0.39 for 
correlations between coarse CAP and NO2, 
p < 0.01; r-values for fine CAP verses gases 
were also within this range).
Table 2 presents the regression results 
for changes in blood biomarker concentra-
tions per 100-μg/m3 increase in CAP mass 
concentrations. Exposure to coarse CAP was 
associated with increased VEGF at 1 hr post-
exposure in two-pollutant models. Adding 
gases in the models as a covariate strength-
ened the associations between coarse CAP and 
VEGF resulting in larger magnitude of effect 
estimates and smaller p-values, suggesting that 
gases may have moderately confounded the 
results for coarse CAP; without adjusting for 
gases in models, the association with coarse 
CAP might be underestimated. Exposure to 
coarse CAP was not significantly associated 
with IL-6, CRP, ET-1, and MDA. Exposure 
to fine CAP was not consistently associated 
with any of the blood biomarkers, and ultra-
fine CAP appears to be negatively associated 
with VEGF at 21 hr postexposure in single- 
and two-pollutant models.
Figure 1 presents the associations between 
endotoxin in CAPs and biomarker concen-
trations in blood. Endotoxin in coarse CAP 
was significantly associated with increased 
VEGF at 1 hr postexposure. Endotoxin was 
not associated with other blood biomarkers. 
Glucan was not associated with any of 
the blood biomarkers (see Supplemental 
Material, Table S2).
Table 3 shows the regression results for 
changes in urinary biomarkers per 100-μg/m3 
increase in CAP mass concentrations. 
Exposures to coarse and ultrafine CAPs were 
Table 1. Pollutant concentrations in the exposure airstream.
Exposure/pollutant n Mean ± SD
Study of coarse and fine CAPs
Filtered ambient air
PM (μg/m3) 29 –0.4 ± 13.5
Endotoxin [ln(ng/m3)] 29 0.5 ± 0.3
β-Glucan [ln(pg/m3)] 29 7.1 ± 1.9
SO2 (ppb) 28 1.5 ± 1.7
O3 (ppb) 29 12.6 ± 7.3**
NO2 (ppb) 26 20.8 ± 12.2**
CO (ppm) 29 0.3 ± 0.1**
Filtered medical air
PM (μg/m3) 41 2.0 ± 8.8
Endotoxin [ln(ng/m3)] ND ND
β-Glucan [ln(pg/m3)] ND ND
SO2 (ppb) 41 1.1 ± 1.0
O3 (ppb) 41 1.0 ± 2.1
NO2 (ppb) 41 1.2 ± 4.6
CO (ppm) 40 0.5 ± 0.2
Coarse CAP
PM (μg/m3) 76 212.9 ± 52.0
Endotoxin [ln(ng/m3)] 74 2.0 ± 1.1*
β-Glucan [ln(pg/m3)] 61 10.5 ± 2.3*
SO2 (ppb) 75 2.5 ± 2.8**
O3 (ppb) 76 13.2 ± 7.2**
NO2 (ppb) 68 19.5 ± 9.6**
CO (ppm) 75 0.3 ± 0.1**
Fine CAP
PM (μg/m3) 29 238.4 ± 62.0
Endotoxin [ln(ng/m3)] 28 2.0 ± 0.6*
β-Glucan [ln(pg/m3)] 25 9.3 ± 1.1*
SO2 (ppb) 28 1.5 ± 1.2
O3 (ppb) 29 11.2 ± 6.7**
NO2 (ppb) 26 17.4 ± 8.6**
CO (ppm) 28 0.3 ± 0.1**
Study of ultrafine CAP
Filtered medical air
PM (μg/m3) 25 8.8 ± 21.1
Particle number (count/cm3) 25 16,405 ± 53,152
Endotoxin [ln(ng/m3)] ND ND
β-Glucan [ln(pg/m3)] ND ND
SO2 (ppb) 25 1.6 ± 1.2
O3 (ppb) 25 1.0 ± 1.6
NO2 (ppb) 25 3.5 ± 6.8
CO (ppm) 25 0.5 ± 0.2
Ultrafine CAP
PM (μg/m3) 25 135.8 ± 67.2**
Particle number (count/cm3) 25 227,767 ± 63,902**
Endotoxin [ln(ng/m3)] 6 0.12 ± 0.01
β-Glucan [ln(pg/m3)] 6 9.0 ± 1.3
SO2 (ppb) 25 2.5 ± 1.5**
O3 (ppb) 25 5.1 ± 6.2**
NO2 (ppb) 25 12.1 ± 8.4**
CO (ppm) 25 0.3 ± 0.2**
ND, not detectable. 
*Significantly different from filtered ambient air, p < 0.05. **Significantly different from filtered medical air, p < 0.05. 
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associated with increased urinary 8-OHdG 
at 1 hr postexposure, and exposure to fine 
CAP was associated with increased MDA at 
1 hr and 21 hr postexposure, in single- and 
two-pollutant models. Fine CAP showed a 
consistent trend of association with urinary 
VEGF at 1 hr postexposure in single- and 
two-pollutant models (p-values 0.07–0.10). 
Adding gases in the models as a covariate 
moderately strengthened the associations 
between CAPs and urinary biomarkers by 
rendering smaller p-values, but the magnitude 
Figure 1. Mean changes in blood biomarker concentrations (95% CI) per unit [ln(ng/m3)] increase in endotoxin in coarse or fine CAP. The number of observations 
was 142–146 and 99 for exposures to endotoxin in coarse and fine CAP, respectively.
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Table 2. Mean changes in blood biomarker concentrations (95% CI) per 100-μg/m3 increase in CAP mass concentration in single- and two-pollutant models.
Model
Coarse CAP Fine CAP Ultrafine CAP
1-hr postexposure 21-hr postexposure 1-hr postexposure 21-hr postexposure 1-hr postexposure 21-hr postexposure
IL-6 (pg/mL)
CAP alone 0.00 (–0.21, 0.21) –0.05 (–0.23, 0.12) –0.05 (–0.14, 0.04) –0.01 (–0.15, 0.12) –0.02 (–0.52, 0.48) –0.05 (–0.32, 0.23)
+ SO2 –0.02 (–0.23, 0.20) –0.10 (–0.28, 0.09) –0.06 (–0.15, 0.04) –0.05 (–0.19, 0.10) –0.02 (–0.53, 0.49) –0.05 (–0.33, 0.23)
+ O3 –0.02 (–0.23, 0.20) –0.04 (–0.23, 0.15) –0.05 (–0.15, 0.04) –0.01 (–0.16, 0.13) –0.02 (–0.52, 0.49) –0.01 (–0.27, 0.24)
+ NO2 0.02 (–0.21, 0.24) –0.10 (–0.31, 0.10) –0.05 (–0.15, 0.05) –0.04 (–0.19, 0.12) –0.03 (–0.56, 0.49) –0.06 (–0.34, 0.23)
+ CO 0.01 (–0.21, 0.22) –0.04 (–0.24, 0.17) –0.06 (–0.16, 0.04) –0.02 (–0.17, 0.13) 0.07 (–0.44, 0.58) 0.00 (–0.28, 0.29)
CRP (ng/mL)
CAP alone –2.84 (–9.98, 4.31) –4.12 (–12.73, 4.49) 3.73 (–5.10, 12.56) –10.98 (–27.71, 5.76) 85.0 (–14.1, 184.2) –28.2 (–155.3, 98.9)
+ SO2 –5.92 (–13.58, 1.74) –7.15 (–16.39, 2.10) 2.63 (–6.32, 11.58) –9.40 (–26.69, 7.88) –62.7 (–460.2, 334.8) –76.9 (–744.3, 590.5)
+ O3 –2.17 (–10.03, 5.69) –7.78 (–17.51, 1.94) 1.87 (–7.94, 11.68) –14.07 (–32.37, 4.24) –63.6 (–442.3, 315.1) –86.5 (–765.0, 592.0)
+ NO2 –0.03 (–8.39, 8.33) –9.53 (–19.31, 0.26) 3.06 (–6.55, 12.67) –9.67 (–26.84, 7.50) –137.4 (–521.6, 246.8) –43.7 (–742.2, 654.8)
+ CO –4.37 (–12.00, 3.26) –3.49 (–12.68, 5.71) 2.38 (–7.06, 11.82) –15.90 (–35.46, 3.66) –43.1 (–447.8, 361.6) –192.5 (–881.8, 496.8)
ET-1 (pg/mL)
CAP alone –0.01 (–0.06, 0.04) 0.00 (–0.04, 0.05) 0.04 (–0.03, 0.10) 0.00 (–0.04, 0.04) 0.08 (–0.20, 0.37) –0.02 (–0.21, 0.17)
+ SO2 –0.02 (–0.07, 0.03) 0.01 (–0.04, 0.05) 0.03 (–0.04, 0.10) 0.00 (–0.05, 0.04) 0.08 (–0.21, 0.37) –0.02 (–0.21, 0.18)
+ O3 –0.01 (–0.07, 0.04) 0.01 (–0.04, 0.05) 0.04 (–0.03, 0.11) 0.00 (–0.05, 0.05) 0.09 (–0.20, 0.38) –0.02 (–0.22, 0.17)
+ NO2 –0.01 (–0.06, 0.04) 0.01 (–0.04, 0.06) 0.04 (–0.03, 0.11) 0.01 9 (–0.03, 0.06) 0.11 (–0.19, 0.41) 0.00 (–0.21, 0.21)
+ CO –0.01 (–0.07, 0.04) 0.00 (–0.04, 0.05) 0.05 (–0.02, 0.12) 0.01 (–0.04, 0.05) 0.11 (–0.19, 0.41) 0.00 (–0.21, 0.20)
VEGF (pg/mL)
CAP alone 1.45 (–0.37, 3.28) –0.01 (–2.77, 2.75) –0.18 (–2.58, 2.21) –0.02 (–3.57, 3.53) –2.25 (–8.10, 3.60) –8.38 (–17.23, 0.48)*
+ SO2 1.63 (–0.27, 3.54)* –0.23 (–3.08, 2.62) –0.04 (–2.52, 2.45) 0.72 (–2.98, 4.43) –2.27 (–8.20, 3.65) –8.29 (–17.25, 0.68)*
+ O3 2.41 (0.41, 4.40)** 1.29 (–1.70, 4.28) 0.50 (–1.98, 2.98) 0.80 (–2.90, 4.50) –2.31 (–8.22, 3.61) –8.34 (–17.34, 0.67)*
+ NO2 2.14 (0.10, 4.18)** 0.65 (–2.71, 4.01) –0.09 (–2.71, 2.52) 0.91 (–2.86, 4.68) –1.69 (–7.97, 4.59) –6.22 (–15.50, 3.06)
+ CO 1.64 (–0.27, 3.54)* 1.00 (–1.22, 3.23) 0.10 (–2.49, 2.68) 0.54 (–2.34, 3.41) –1.53 (–7.48, 4.41) –0.97 (–9.61, 7.67)
MDA (μM)
CAP alone 0.00 (–0.11, 0.12) –1.93 (–4.84, 0.99) –0.10 (–0.24, 0.05) –1.73 (–4.23, 0.76) 0.00 (–0.27, 0.27) –0.04 (–0.29, 0.20)
+ SO2 0.00 (–0.12, 0.12) –1.91 (–4.83, 1.01) –0.07 (–0.21, 0.07) –1.70 (–4.20, 0.81) 0.00 (–0.27, 0.28) –0.05 (–0.29, 0.20)
+ O3 0.00 (–0.13, 0.13) –1.98 (–4.91, 0.94) –0.09 (–0.24, 0.06) –1.73 (–4.25, 0.78) 0.00 (–0.27, 0.27) –0.06 (–0.29, 0.18)
+ NO2 0.00 (–0.13, 0.13) –1.95 (–4.99, 1.09) –0.16 (–0.31, –0.01)** –1.78 (–4.38, 0.81) –0.02 (–0.31, 0.26) –0.13 (–0.37, 0.11)
+ CO 0.00 (–0.12, 0.13) –2.03 (–4.95, 0.89) –0.07 (–0.22, 0.08) –1.86 (–4.42, 0.69) 0.03 (–0.25, 0.32) 0.04 (–0.21, 0.28)
*p < 0.1. **p < 0.05.
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of the associations did not change markedly, 
suggesting that gases may have minor 
confounding influence over the results for 
CAPs. Nevertheless, not adjusting for gases 
might underestimate the strength of the asso-
ciations. The number count variable for ultra-
fine CAP yielded similar regression outcomes 
(see Supplemental Material, Table S3).
Figure 2 shows the associations between 
endotoxin in CAPs and urinary biomarkers. 
Endotoxin in coarse and fine CAPs was asso-
ciated with increased urinary VEGF at 1 hr 
postexposure. Endotoxin in coarse CAP was 
associated with increased 8-OHdG at 1 hr 
postexposure. Exposure to endotoxin in fine 
CAP was associated with increased urinary 
MDA at 1 hr and 21 hr postexposure at 
p-values 0.08 and 0.07, respectively. Glucan 
was not associated with any urinary biomarkers 
(see Supplemental Material, Table S2).
Discussion
Our results demonstrate that exposure to 
coarse CAP was associated with increased 
blood VEGF and urinary 8-OHdG concentra-
tions, whereas exposure to fine CAP was asso-
ciated with increased urinary VEGF and MDA 
concentrations. Exposure to ultrafine CAP was 
associated with increased urinary 8-OHdG. 
These biomarker changes were transitory, 
lasting < 21 hr postexposure. These associations 
were robust after adjusting for age, sex, BMI, 
and season in the models. Adding gaseous 
pollutants in the models typically strength-
ened the associations by reducing p-values and 
slightly increasing the magnitude of effect esti-
mates, suggesting that these gases may have 
moderately confounded the results for CAPs. 
The confounding possibly was attributable 
to the gases not removed in the airstreams of 
filtered ambient air and CAPs. Not adjusting 
for these gases in the models might under-
estimate the effects of CAPs. All results taken 
together, on an equal mass concentration basis 
(per 100 μg/m3), the three particle size frac-
tions affected blood and urinary biomarkers 
in different ways: Coarse CAP appears to have 
more influence on blood VEGF, fine CAP 
more influence over urinary MDA, and ultra-
fine CAP more effect on urinary 8-OHdG. 
Regression results for endotoxin mirrored 
those found in coarse or fine CAPs where 
endotoxin was collected, suggesting that endo-
toxin in CAPs contributed to systemic changes 
in vascular mediators and oxidative stress.
We used VEGF and ET-1 as biomarkers 
of vascular function, and found that coarse 
CAP and the endotoxin constituent in coarse 
and fine CAPs were associated with a tran-
sient increase in blood and urinary VEGF 
levels. VEGF regulates the mobilization of 
endothelial progenitor cells from bone 
marrow to an injured site (Haberzettl et al. 
2012). Increased VEGF levels may represent 
an acute systemic response to endothelial 
injury during exposure to PM and endotoxin. 
Daily exposure to indoor and outdoor PM2.5 
and black carbon has been associated with 
increased blood VEGF levels in seniors (Liu 
et al. 2009b). To our knowledge, the present 
study is the first to report an association 
between exposure to ambient PM and endo-
toxin and elevated urinary VEGF levels. ET-1 
is an endogenous vasoconstrictor (Haynes 
et al. 1996). Elevated plasma ET-1 was found 
in children who were chronically exposed 
to air pollution in Mexico City (Calderón-
Garcidueñas et al. 2007) and in seniors on 
high-pollution days (Liu et al. 2009b). In the 
present study, we did not observe changes 
in blood ET-1. This discrepancy might be 
attributable to differences in the participants’ 
demographics and health status compared to 
other cited studies.
Overproduction of IL-6 induces immune-
mediated inflammatory diseases (Nishimoto 
and Kishimoto 2006). CRP is an acute-phase 
Table 3. Mean changes in urinary biomarker concentrations (95% CI) per 100-μg/m3 increase in CAP mass concentration in single- and two-pollutant models.
Biomarker/model
Coarse CAP Fine CAP Ultrafine CAP 
1 hr postexposure 21 hr postexposure 1 hr postexposure 21 hr postexposure 1 hr postexposure 21 hr postexposure
VEGF (pg/mg creatinine)
CAP alone 8.23 (–2.68, 19.14) 6.61 (–5.34, 18.55) 9.10 (–0.98, 19.17)* 5.60 (–4.78, 15.98) 4.40 (–17.88, 26.69) 9.16 (–12.80, 31.11)
+ SO2 7.33 (–3.92, 18.59) 3.52 (–8.95, 16.00) 8.88 (–1.41, 19.18)* 4.39 (–6.52, 15.31) 4.11 (–1.93, 10.15) 8.14 (–12.87, 29.15)
+ O3 6.31 (–5.48, 18.11) 6.45 (–6.53, 19.43) 7.47 (–3.09, 18.03) 5.64 (–5.32, 16.60) 4.65 (–2.11, 11.40) 9.39 (–12.70, 31.47)
+ NO2 6.87 (–5.66, 19.41) 6.42 (–7.29, 20.13) 9.89 (–1.86, 21.65) 4.31 (–7.22, 15.84) 3.86 (–2.71, 10.43) 16.11 (–6.51, 38.73)
+ CO 10.95 (–0.30, 22.20)* 8.24 (–4.17, 20.65) 10.26 (–0.79, 21.31)* 8.95 (–2.27, 20.16) 2.08 (–4.91, 9.07) 9.12 (–14.04, 32.28)
8-OHdG (ng/mg creatinine)
CAP alone 0.24 (–0.02, 0.50)* 0.01 (–0.26, 0.27) –0.19 (–0.55, 0.17) –0.19 (–0.50, 0.13) 0.69 (0.09, 1.29)** 0.19 (–0.41, 0.79)
+ SO2 0.29 (0.02, 0.56)** 0.06 (–0.22, 0.35) –0.20 (–0.58, 0.18) –0.20 (–0.52, 0.13) 0.72 (0.09, 1.34)** 0.18 (–0.42, 0.78)
+ O3 0.22 (–0.07, 0.51) –0.03 (–0.32, 0.27) –0.23 (–0.60, 0.15) –0.18 (–0.51, 0.15) 0.68 (0.09, 1.26)** 0.19 (–0.40, 0.79)
+ NO2 0.27 (–0.03, 0.57)* –0.05 (–0.38, 0.27) –0.20 (–0.62, 0.21) –0.33 (–0.67, 0.01)* 0.76 (0.15, 1.38)** 0.22 (–0.40, 0.84)
+ CO 0.30 (0.04, 0.57)** 0.02 (–0.26, 0.30) –0.12 (–0.50, 0.26) –0.18 (–0.51, 0.16) 0.57 (0.00, 1.15)** 0.29 (–0.34, 0.91)
MDA (nmol/mg creatinine)
CAP alone 0.07 (–0.09, 0.23) 0.05 (–0.18, 0.29) 0.31 (0.02, 0.60)** 0.27 (–0.04, 0.57)* 0.15 (–0.13, 0.43) 0.29 (–0.20, 0.78)
+ SO2 0.09 (–0.08, 0.26) 0.09 (–0.16, 0.34) 0.31 (0.02, 0.60)** 0.23 (–0.07, 0.54) 0.18 (–0.11, 0.48) 0.29 (–0.20, 0.79)
+ O3 0.05 (–0.13, 0.23) 0.02 (–0.25, 0.28) 0.36 (0.06, 0.66)** 0.29 (–0.04, 0.62)* 0.15 (–0.13, 0.44) 0.29 (–0.20, 0.78)
+ NO2 0.01 (–0.18, 0.19) –0.03 (–0.29, 0.24) 0.24 (–0.08, 0.57) 0.21 (–0.13, 0.55) 0.11 (–0.19, 0.41) 0.28 (–0.25, 0.80)
+ CO 0.06 (–0.11, 0.23) 0.04 (–0.21, 0.29) 0.31 (0.00, 0.63)** 0.26 (–0.08, 0.59) 0.10 (–0.22, 0.41) 0.26 (–0.26, 0.78)
*p < 0.1. **p < 0.05.
Figure 2. Mean changes in urinary biomarker concentrations (95% CI) per unit [ln(ng/m3)] increase in endotoxin in coarse or fine CAP. The number of observations 
was 143 and 98 for exposures to endotoxin in coarse and fine CAP, respectively.
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reactant marker for underlying systemic 
inflammation and a strong predictor for 
atherosclerosis, coronary artery disease, and 
myocardial infarction (Anderson et al. 1998). 
In the present study, CAPs were not associated 
with any changes in blood IL-6 and CRP. 
There is conflicting evidence in the literature 
about the influence of air pollution on blood 
IL-6 and CRP. Increased IL-6 and/or CRP 
were reported in a controlled exposure study 
(Urch et al. 2010) and epidemiological studies 
(Delfino et al. 2009). Other studies found 
either no association between exposure to 
PM and IL-6 and CRP (Behbod et al. 2013; 
Bräuner et al. 2008; Liu et al. 2009b), or 
an association between PM and a reduction 
in CRP levels (Rückerl et al. 2007). These 
discrepancies among studies may be attributed 
to different characteristics of study partici-
pants or different particle compositions. It is 
also possible that CRP and IL-6 were not very 
sensitive to a 130-min exposure to PM.
8-OHdG is a by-product from damaged 
DNA when it is attacked by hydroxyl free 
radicals at deoxyguanosine in DNA (Park 
and Floyd 1992). We found significant 
associations between urinary 8-OHdG at 
1 hr postexposure and coarse and ultrafine 
CAPs, and endotoxin collected with coarse 
CAP. These findings are consistent with a 
previous report that elevated ambient ultra-
fine particle concentrations were associated 
with increases in children’s urinary 8-OHdG 
(Song et al. 2013). MDA is formed during 
oxidative degradation of cellular lipids (Janero 
1990). Our results show that urinary MDA 
was associated with exposure to fine CAP 
and endotoxin collected with fine CAP. Fine 
particulate pollutants have been demonstrated 
to cause formation of excessive amount of 
reactive oxygen species in airways and the 
cardiovascular system in experimental animals, 
leading to tissue inflammation and cell death 
(Dye et al. 1997). Our results provide further 
supporting evidence that ambient coarse, fine, 
and ultrafine PM may facilitate oxidative 
damage to DNA or membrane lipids.
We found that endotoxin from CAPs was 
associated with increases in blood and urinary 
VEGF, and urinary MDA and 8-OHdG. In 
an early study, we reported that endotoxin was 
associated with increased blood leucocytes and 
neutrophils 24 hr postexposure, regardless of 
the origin (coarse or fine CAP) of endotoxin 
(Behbod et al. 2013). These findings suggest 
that endotoxin as a component of outdoor 
PM may contribute to damage to important 
macromolecules leading to tissue injury. 
Although the levels of endotoxin in coarse and 
fine CAPs were similar, exposures to coarse 
and fine CAPs themselves were not associ-
ated with the same changes in biomarkers. 
Moreover, endotoxin in coarse and fine 
CAPs was associated with different biomarker 
responses. One explanation for this may 
be that the differences in airway deposition 
location and rates for coarse and fine CAPs 
(as well as endotoxin carried by them) may 
have influenced their effects on biomarkers. 
It is also possible that other constituents in 
CAPs such as metals and organic carbon may 
have contributed to the effects by CAPs as 
well. We have archived CAP samples for future 
 investigations of PM constituents.
In conclusion, in this study we found that 
a 130-min exposure to concentrated ambient 
PM was associated with changes in blood and 
urinary biomarkers for vascular function and 
oxidative stress that influenced DNA and 
cellular lipid integrity in humans. The three 
size fractions of CAPs appear to affect these 
biomarkers in a different manner, with coarse 
CAP having a stronger association with VEGF 
in blood, fine CAP having stronger associa-
tion with urinary marker of lipid peroxidation, 
and ultrafine CAP having a stronger associa-
tion with urinary marker of DNA oxidative 
damage. Endotoxin constituents for coarse and 
fine CAPs were significantly associated with 
systemic changes in VEGF and the biomarkers 
of DNA and lipid oxidation, suggesting that 
endotoxin played a role in the effects of coarse 
and fine CAPs on human health.
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